Curiox Biosystems Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	13,083	17,909	5,597	11,003	7,043
Short-Term Investments	-	-	3,125	8,816	809.54
Cash & Short-Term Investments	13,083	17,909	8,722	19,819	7,853
Cash Growth	119.25%	105.34%	-55.99%	152.38%	-
Accounts Receivable	803.76	1,723	1,832	1,240	1,146
Other Receivables	86.42	98.19	68.97	86.29	86.63
Receivables	890.18	1,821	1,901	1,326	1,232
Inventory	1,649	1,621	2,911	1,759	595.7
Prepaid Expenses	262.01	173.81	79.92	23.37	12.77
Other Current Assets	125.84	75.54	336.57	132.05	197.54
Total Current Assets	16,010	21,601	13,949	23,060	9,891
Property, Plant & Equipment	2,229	2,391	998.06	543.1	427.33
Long-Term Investments	-	-	-	0	-0
Goodwill	24,653	23,547	22,733	21,143	19,819
Other Intangible Assets	9,958	10,056	10,761	10,969	11,196
Other Long-Term Assets	196.69	203.37	185.77	78.5	32.68
Total Assets	53,046	57,798	48,627	55,793	41,367
Accounts Payable	178.54	330	929.48	937.19	127.39
Accrued Expenses	424.13	375.03	537.34	441.11	201
Short-Term Debt	-	-	-	30,148	11,857
Current Portion of Leases	381.58	358.97	219.12	56.96	25.65
Current Unearned Revenue	577.37	669.72	539.41	286.02	107.22
Other Current Liabilities	525.72	982.85	609.44	411.63	353.16
Total Current Liabilities	2,087	2,717	2,835	32,281	12,672
Long-Term Debt	-	-	-	-	126.73
Long-Term Leases	448.08	606.19	168.09	241.58	157.86
Long-Term Deferred Tax Liabilities	1,691	1,592	1,764	1,564	1,734
Other Long-Term Liabilities	-	-	0	0	-0
Total Liabilities	4,227	4,915	4,767	34,087	14,690
Common Stock	4,017	4,011	3,284	543	543
Additional Paid-In Capital	89,106	88,965	71,651	27,944	27,944
Retained Earnings	-51,199	-45,466	-35,426	-23,931	-9,407
Comprensive Income & Other	6,891	5,369	4,344	1,027	-1,805
Total Common Equity	48,815	52,879	43,853	5,582	17,274
Minority Interest	4.72	4.93	7.82	10.82	10.13
Shareholders' Equity	48,820	52,883	43,861	21,707	26,677
Total Liabilities & Equity	53,046	57,798	48,627	55,793	41,367
Total Debt	829.66	965.16	387.21	30,446	12,168
Net Cash (Debt)	12,253	16,944	8,334	-10,627	-4,315
Net Cash Growth	116.93%	103.30%	-	-	-
Net Cash Per Share	778.05	1186.03	1174.42	-1630.92	-662.17
Filing Date Shares Outstanding	16.07	16.04	13.14	6.52	6.52
Total Common Shares Outstanding	16.07	16.04	13.14	6.52	6.52
Working Capital	13,923	18,884	11,115	-9,221	-2,781
Book Value Per Share	3038.24	3295.64	3337.89	856.64	2651.04
Tangible Book Value	14,204	19,276	10,359	-26,530	-13,741
Tangible Book Value Per Share	884.09	1201.37	788.46	-4071.57	-2108.88
Machinery	-	2,440	1,219	740.14	704.78

Source: S&P Capital IQ. Standard template. Financial Sources.